Quantitative Evaluation and Optimization of Co-drugging to Improve Anti-HIV Latency Therapy
Wong VC, Fong LE, Adams NM, Xue Q, Dey SS, Miller-Jensen K. Quantitative Evaluation and Optimization of Co-drugging to Improve Anti-HIV Latency Therapy. Cellular And Molecular Bioengineering 2014, 7: 320-333. PMID: 26191086, PMCID: PMC4501041, DOI: 10.1007/s12195-014-0336-9.Peer-Reviewed Original ResearchLatency-reversing agentsLatent infectionSingle drugPrimary T-cell modelLatent cellular reservoirsActivation thresholdHistone deacetylase inhibitorsT cell modelLatent HIVUnwanted side effectsInfected patientsCellular reservoirsDrug interactionsTherapeutic strategiesSide effectsRepeat stimulationDeacetylase inhibitorsViral activationInfectionFurther studiesHIVViral integrationDrugsCell modelViral promoters
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply